Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MGX compared with CATO: revenue, margins and what each company keeps, and the suppliers and customers both name
MGX
Metagenomi Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
CATO
Cato Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
MGX
Metagenomi Therapeutics, Inc.
vs
CATO
Cato Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MGX: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MGX
2
IONS
Ionis Pharmaceuticals
customer
—
Acuitas Therapeutics
unlisted
supplier
Shared
0
No disclosed counterparties: CATO.
Only CATO
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MGX, solid
CATO, dashed
MGX
Metagenomi Therapeutics, Inc.
Change
0.80
▲
+1.96%
· post 0.77
Mkt cap
$29.5M
Revenue
$1M
Q1 FY26
Revenue
$25M
FY25
CATO
Cato Corp
Change
2.31
0.00%
Closed
Nov 2 '26
Mkt cap
$46.0M
Revenue
$166M
Q2 FY26
Revenue
$654M
FY25
vs
Compare
Closed
Nov 2 '26
MGX
Metagenomi Therapeutics, Inc.
vs
CATO
Cato Corp
0.80
▲
+1.96%
post 0.77
Price
2.31
0.00%
$29.5M
Mkt cap
$46.0M
Q1 FY26
$1M
Revenue
$166M
Q2 FY26
FY25
$25M
Revenue
$654M
FY25
Change
Change
MGX
0.80
▲
+1.96%
vs
CATO
2.31
0.00%
Closed
Nov 2 '26